Ra Medical Systems Stock News

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday

Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q4 2021 Results - Earnings Call Transcript

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial

Biotech penny stocks to watch right now. The post Best Penny Stocks To Buy?

Reddit penny stocks under $1 to watch this week. The post 5 Penny Stocks Under $1 To Buy According To Redditors This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc

Check these three penny stocks out for your March watchlist The post Buying Penny Stocks in March 2022? Check These 3 Out  appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt

Biotech penny stocks to watch as Ukraine-Russia conflict builds steam. The post Biotech Penny Stocks To Buy For Under $5 As Russia Ukraine Conflict Heats Up appeared first on Penny Stocks to Buy, Pick

In the last trading session, 3.47 million shares of the Ra Medical Systems Inc. (AMEX:RMED) were traded, and its beta was 1.57. Most recently the company’s share price was $0.38, and it changed around -$0.02 or -4.08% from the last close, which brings the market valuation of the company to $10.17M. RMED currently trades at … Ra Medical Systems Inc. (AMEX: RMED) Stock Forecast 2022: Profitable With Bullish Signals Read More »

Ra Medical Systems (RMED) slumps 52.2% in premarket after pricing its underwritten public offering of units for gross proceeds of ~$12M.Offering consists of 9.54M units priced at a

Ra Medical Systems Inc  RMED has priced an underwritten public offering of 9.535 million units at $0.50 per unit for approximately $12.0 million in gross proceeds. Get the Inside Access Traders Are

Ra Medical Systems Inc (RMED) shares closed today at 1.9% above its 52 week low of $1.35, giving the company a market cap of $9M. The stock is currently down 11.9% year-to-date, down 80.3% over the past 12 months, and down 99.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 41.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -22.0% The company's stock price performance over the past 12 months lags the peer average by 352.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Vanguard Group Inc. increased its stake in shares of Ra Medical Systems, Inc. (NYSE:RMED) by 275.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 145,161 shares of the companys stock after buying an additional 106,451 shares during the quarter. Vanguard []

During the last session, Ra Medical Systems Inc. (AMEX:RMED)s traded shares were 0.63 million. At the end of the trading day, the stocks price was $2.57, reflecting an intraday gain of 6.20% or $0.15. The 52-week high for the RMED share is $9.82, that puts it down -282.1 from that peak though still a striking Is Ra Medical Systems Inc.s (AMEX: RMED) -3.38% Loss This Week Telling Us Something New? Read More »

Some of the key players in the global dermatology excimer laser market are: Lumenis, Ra Medical Systems, Sincoheren, Hologic, Shenzhen GSD Tech, Fotona, Fosun International Holdings, etc. Some of the key players in the global dermatology excimer laser market are: Lumenis, Ra Medical Systems, Sincoheren, Hologic, Shenzhen GSD Tech, Fotona, Fosun International Holdings, etc.